市場調查報告書
商品編碼
1029210

再生醫療的全球市場 (2021-2026年):產業趨勢、市場佔有率、市場規模、成長預測、市場機會

Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 142 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球再生醫療的市場規模2020年表現119億4000萬美元的規模,在預測期間中22.7%的年複合成長率成長。

慢性疾病和遺傳性疾病全球的抱了增加肌肉骨骼系統,腫瘤,皮膚科,心臟等,各種疾病的老年人增加,器官移植的普及等要素促進該市場成長。還有3D生物印刷技術開發、再生醫療產品的製造中AI的採用等,細胞為基礎治療的各種技術的進步也成為促進成長的要素。

本報告提供全球再生醫療的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,市場規模的變化、預測,類型、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 調查範圍、調查手法

第3章 摘要整理

第4章 簡介

第5章 世界市場趨勢

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場分析、預測:各類型

  • 幹細胞治療
  • 生物材料
  • 組織工程
  • 其他

第7章 市場分析、預測:各用途

  • 移植骨替代物
  • 骨關節疾病
  • 皮膚科
  • 心血管
  • 中樞神經系統
  • 其他

第8章 市場分析、預測:各終端用戶

  • 醫院
  • 專門診所
  • 其他

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東、非洲

第10章 SWOT分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 價格分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Allergan PLC(AbbVie Inc.)
    • Amgen Inc.
    • Baxter International Inc.
    • BD(Becton, Dickinson and Company)
    • Integra Lifesciences Holdings Corporation
    • Medtronic Plc
    • Mimedx Group Inc.
    • Novartis AG
    • Osiris Therapeutics Inc.(Smith & Nephew plc)
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1020F160_Report

The global regenerative medicine market reached a value of US$ 11.94 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 22.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer's, Parkinson's and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.

The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and end user.

Breakup by Type:

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Breakup by Application:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:

  • How has the global regenerative medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global regenerative medicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global regenerative medicine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regenerative Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Tissue Engineering
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dermatology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Central Nervous System
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan PLC (AbbVie Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BD (Becton, Dickinson and Company)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra Lifesciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mimedx Group Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2020
  • Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2020
  • Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2020
  • Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
  • Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
  • Figure 84: Global: Regenerative Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2021-2026
  • Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Regenerative Medicine Market Structure
  • Table 7: Global: Regenerative Medicine Market: Key Players